Takeru Funakoshi (Ikuko Hirai)

Researcher Name Resolver ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

The Journal of dermatology

Experimental dermatology

Medicine

The Journal of experimental medicine

University of Pennsylvania

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pennsylvania Aug 01 2009 - Jul 31 2010

United States

Visiting Scholar :: Dermatology

Publications

Ikuko Hirai, Keiji Tanese, Yoshio Nakamura, Keitaro Fukuda, Takeshi Ouchi, Tetsu Hayashida, Kaori Kameyama, Takayuki Abe, Masayuki Amagai, Takeru Funakoshi
Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC). The oncologist (2024)
Takuya Maeda, Teruki Yanagi, Keiko Tokuchi, Takeru Funakoshi, Nao Horie, Toshiyuki Isoe, Yoichi M Ito, Norihiro Sato, Hideyuki Ujiie
Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single-arm phase II trial. Experimental dermatology 33 (1) (2024)
Takeru Funakoshi, Yoshio Nakamura, Ikuko Hirai, Kenta Kobayashi, Keitaro Fukuda, Taku Iwata
Proposal for the optimal staging of extramammary Paget's disease: A retrospective analysis of 57 cases with distant metastasis. Experimental dermatology 33 (2) (2024)
Takuya Maeda, Teruki Yanagi, Keiko Tokuchi, Takeru Funakoshi, Nao Horie, Toshiyuki Isoe, Yoichi M Ito, Norihiro Sato, Hideyuki Ujiie
Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single-arm phase II trial. Experimental dermatology 33 (1) (2024)
Takeru Funakoshi, Yoshio Nakamura, Ikuko Hirai, Kenta Kobayashi, Keitaro Fukuda, Taku Iwata
Proposal for the optimal staging of extramammary Paget's disease: A retrospective analysis of 57 cases with distant metastasis. Experimental dermatology 33 (2) (2024)
Takaiyuki Fusumae, Keitaro Fukuda, Ikuko Hirai, Yoshio Nakamura, Kenta Kobayashi, Keiji Tanese, Kazuhiro Matsumoto, Takashi Iwata, Takeru Funakoshi
Management and outcomes of hydronephrosis in patients with metastatic extramammary Paget's disease: A retrospective analysis. The Journal of dermatology 49 (8) (2022)
Ikuko Hirai, Keiji Tanese, Keitaro Fukuda, Takayuki Fusumae, Yoshio Nakamura, Yasunori Sato, Masayuki Amagai, Takeru Funakoshi
Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: A phase I/II trial and study protocol. Medicine 100 (49) (2022)
Yuuri Nakajima, Takaiyuki Fusumae, Takeru Funakoshi, Yoshio Nakamura, Tomoaki Mori, Robert Nakayama, Marie Tsuchiya, Rena Hashimoto, Takeru Funakoshi
Congenital dermatofibrosarcoma protuberans presenting as a depressed plaque: Clinical presentation and chronology. The Journal of dermatology (2022)
Keitaro Fukuda, Ken Okamura, Rebecca L Riding, Xueli Fan, Khashayar Afshari, Nazgol-Sadat Haddadi, Sean Matthew McCauley, Mehmet Hakan Guney, Jeremy Luban, Takeru Funakoshi, Tomonori Yaguchi, Yutaka Kawakami, Anastasia Khvorova, Katherine A Fitzgerald, John E Harris
AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma. The Journal of experimental medicine 218 (9) (2021)
Yoshihiro Ishida, Nobuyuki Kakiuchi, Kenichi Yoshida, Yoshikage Inoue, Hiroyuki Irie, Tatsuki R Kataoka, Masahiro Hirata, Takeru Funakoshi, Shigeto Matsushita, Hiroo Hata, Hiroshi Uchi, Yuki Yamamoto, Yasuhiro Fujisawa, Taku Fujimura, Ryunosuke Saiki, Kengo Takeuchi, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Atsushi Otsuka, Satoru Miyano, Kenji Kabashima, Seishi Ogawa
Unbiased Detection of Driver Mutations in Extramammary Paget Disease. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (6) (2020)
Maki Ishii, Ikuko Hirai, Keiji Tanese, Takayuki Fusumae, Yoshio Nakamura, Keitaro Fukuda, Hiroshi Uchi, Kenji Kabashima, Atsushi Otsuka, Kenji Yokota, Naoya Yamazaki, Kenjiro Namikawa, Taku Fujimura, Tatsuya Takenouchi, Yuki Yamamoto, Mana Nishiguchi, Yasunori Sato, Masayuki Amagai, Takeru Funakoshi
Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study). Medicine 99 (44) (2020)
Chihiro Shiiya, Takeshi Ouchi, Takeru Funakoshi, Masayuki Amagai, Hayato Takahashi
Autoimmune and inflammatory diseases occur in cases of drug-induced hypersensitivity syndrome but not in suspected cases. The Journal of dermatology 48 (1) (2020)
Umi Tahara, Keiji Tanese, Yoshio Nakamura, Ikuko Hirai, Masayuki Amagai, Souta Oguro, Takeru Funakoshi
Successful control of adrenal metastasis with transcatheter arterial chemoembolization in metastatic melanoma patient undergoing treatment with immune checkpoint inhibitor. The Journal of dermatology 46 (8) (2019)
Ikuko Hirai, Keiji Tanese, Yoshio Nakamura, Masayuki Amagai, Shuji Mikami, Takeru Funakoshi
Case of metastatic cutaneous myoepithelial carcinoma lacking severe cytological atypia. The Journal of dermatology 47 (3) (2019)
Ikuko Hirai, Takeru Funakoshi
Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease. The Journal of dermatology 44 (10) (2017)

Takeru Funakoshi.css-eqlu8i{font-size:small;padding-left:4px;} (Ikuko Hirai)

Publication Activity (10 Years)

Top Topics

Top Venues

Takeru Funakoshi (Ikuko Hirai)